Detachment of normal epithelial cells from the extracellular matrix triggers apoptosis, a phenomenon called anoikis. Conversely, carcinoma cells tend to be relatively more anoikis-resistant than their normal counterparts, and this increased resistance represents a critical feature of the malignant phenotype. Mechanisms that control susceptibility and resistance to anoikis are not fully understood. It is now known that detachment of non-malignant epithelial cells triggers both pro-and antiapoptotic signals, and it is the balance between these signals and the duration of detachment that determine further fate of the cells. Detachment-induced antiapoptotic events delay anoikis and if cells reattach relatively soon after detachment they survive. Direct regulators of apoptosis responsible for this delay of anoikis are unknown. We found that detachment of non-malignant intestinal epithelial cells triggers upregulation of inhibitors of apoptosis protein (IAP) family, such as X-chromosome-linked inhibitor of apoptosis protein and cellular inhibitor of apoptosis-2 (cIAP2). We demonstrated that this upregulation requires detachmentdependent activation of the transcription factor nuclear factor-jB. We further observed that various IAP antagonists accelerate anoikis, indicating that upregulation of the IAPs delays detachment-triggered apoptosis. We conclude that the IAPs are important regulators of the balance between detachment-triggered life and death signals. Perhaps, not by coincidence, these proteins are often upregulated in carcinomas, tumors composed of cells that tend to be anoikis-resistant.
Introduction
Detachment of epithelial cells from the extracellular matrix (ECM) typically results in apoptosis (Frisch and Francis, 1994; Rak et al., 1995) . This phenomenon is called 'anoikis' (Frisch and Francis, 1994) . Many normal glandular epithelia are organized in vivo into cellular monolayers, which are attached to the form of the ECM known as basement membrane. This adhesion is thought to be essential for the survival of diverse types of normal epithelial cells. In contrast, carcinomas (cancers of epithelial origin) usually represent threedimensional disorganized multicellular masses in which cells are deprived of adhesion to a properly assembled basement membrane, but at least a fraction of these cells remains viable. Thus, carcinoma cells are relatively more anoikis-resistant than their normal counterparts.
Several lines of evidence indicate that resistance of carcinoma cells to anoikis represents a critical prerequisite for tumor progression and metastasis. First, tumorderived cells tend to be anoikis-resistant and, unlike non-malignant cells, often display the ability to survive and grow in the absence of adhesion to the ECM as colonies in soft agar. This property of cancer cells has served as a 'golden standard' for cell transformation for three decades (Freedman and Shin, 1974) . Second, expression of oncogenes, such as ras (Rak et al., 1995) , b-catenin (Orford et al., 1999) , epidermal growth factor receptor and ErbB2 (Reginato et al., 2003) in nonmalignant epithelial cells is known to render these cells anoikis-resistant. Third, loss of oncogenes, such as ras, by carcinoma cells was shown to block their in vivo tumorigenicity and anoikis resistance (Rosen et al., 2000; Liu et al., 2005) . Fourth, re-introduction of tumor suppressor genes, such as phosphatase and tensin homologue deleted on chromosome 10 (PTEN) (Lu et al., 1999) , into PTEN-negative carcinoma cells was demonstrated to render the cells anoikis-susceptible. Fifth, nontumorigenic anoikis-susceptible epithelial cells selected for increased anoikis resistance were found to be tumorigenic in vivo (Rak et al., 1999) . Finally, treatment resulting in the inhibition of anoikis resistance of diverse types of tumor cells was shown to suppress their in vivo tumorigenicity (Rosen et al., 1998 (Rosen et al., , 2000 Scotlandi et al., 2002; Duxbury et al., 2004b) and the ability to metastasize (Scotlandi et al., 2002; Duxbury et al., 2004a, b; Jiang et al., 2004; Berezovskaya et al., 2005) . For example, we found that ras oncogene blocks anoikis of intestinal epithelial cells by downregulating a proapoptotic protein Bak (Rosen et al., 1998) and by upregulating an antiapoptotic protein Bcl-X L (Rosen et al., 2000) . We demonstrated that the reversal of the effects of ras on Bak and Bcl-X L not only inhibits rasdependent anoikis resistance of these cells but also blocks tumorigenicity of ras-transformed cells in vivo (Rosen et al., 1998 (Rosen et al., , 2000 .
Collectively, these data suggest that anoikis resistance of carcinoma cells could serve as a novel tumor-specific therapeutic target. However, no significant effort to develop cancer treatment based on the reversal of anoikis resistance of tumor cells has been undertaken to date. This is mainly owing to the fact that molecular mechanisms that control anoikis of normal and cancer cells are not well understood and have just begun to emerge.
Recent studies indicate that detachment of nonmalignant intestinal and breast epithelial cells triggers not only pro-but also antiapoptotic signals, and it is the balance between these signals that is primarily responsible for the regulation of anoikis (Gilmore et al., 2000; Wang et al., 2003; Loza-Coll et al., 2005; Yan et al., 2005) . It is now thought that the role of detachmenttriggered antiapoptotic mechanisms in the control of anoikis is to delay the onset of this process and thus establish the timing of detachment-induced apoptosis (Loza-Coll et al., 2005; Yan et al., 2005) . These antiapoptotic events allow the cells to survive if the cells are given a chance to re-establish contacts with the ECM relatively soon after detachment. However, detachment-induced survival mechanisms are capable of delaying, rather than completely blocking, detachment-induced apoptosis. If cells are deprived of adhesion to the ECM for an extended period of time, they eventually do undergo anoikis. Thus, in normal epithelial cells, the balance between detachment-induced life and death signals is ultimately shifted toward apoptosis. Conversely, in detached carcinoma cells, it is the survival signals that typically prevail. Therefore, identification of the mechanisms responsible for the regulation of the balance between detachment-dependent life and death signals in normal and cancer cells is essential for understanding the molecular basis of carcinoma progression. Some of the signals that block anoikis in cancer cells have been identified. For example, we found that ras, one of the most frequently occurring oncogenes, blocks anoikis of colorectal cancer cells by multiple mechanisms that include downregulation of the proapoptotic protein Bak and upregulation of antiapoptotic proteins Bcl-X L , cIAP2 and X-chromosomelinked inhibitor of apoptosis protein (XIAP) (Rosen et al., 1998 (Rosen et al., , 2000 Liu et al., 2005) . Presumably, these events disrupt the mechanisms that normally control anoikis of non-malignant cells. The latter mechanisms, however, are not fully understood and, therefore, which of these mechanisms are deregulated in cancer cells is not clear. Thus, the objective of the present study was to identify the events that control the balance between detachment-induced pro-and antiapoptotic signals in non-malignant epithelial cells.
So far, we found that detachment of non-malignant intestinal epithelial cells simultaneously triggers two death-inducing mechanisms, such as those driven by the downregulation of the antiapoptotic protein Bcl-X L (Rosen et al., 2000) and p38 mitogen-activated protein kinase-dependent upregulation of Fas ligand (Rosen et al., 2002) . In addition, detachment of these cells has recently been shown to induce several prosurvival events, such as induction of the transcription factor nuclear factor (NF)-kB (Yan et al., 2005) and activation of c-Src and c-Fyn kinases (Loza-Coll et al., 2005) . These antiapoptotic mechanisms significantly delay the onset of anoikis.
Whether or not epithelial cells survive or die after detachment from the ECM is ultimately determined by the levels of expression and activity of proteins that directly control apoptosis, such as Bcl-2 family members, caspases, their inhibitors, etc. (Rosen et al., 1998 (Rosen et al., , 2000 . Which of these proteins are responsible for the delay of anoikis is presently unknown, and the goal of the present study was to identify these regulators of programmed cell death.
We show here that the detachment of intestinal epithelial cells triggers upregulation of antiapoptotic proteins XIAP and cIAP2. These proteins are known to be able to inhibit the activity of caspases, proapoptotic proteases that are responsible for the execution of programmed cell death (LaCasse et al., 1998) . We further demonstrate that detachment-induced upregulation of these inhibitors of apoptosis proteins (IAPs) delays apoptosis triggered by loss of cell adhesion to the ECM, and thus controls the timing of anoikis. Furthermore, we found that to be able to execute anoikis, several detachment-dependent proapoptotic mechanisms need to cooperate with each other in overcoming the prosurvival effect of the IAPs. Thus, IAPs represent important regulators of the balance between life and death signals in non-malignant intestinal epithelial cells that are deprived of adhesion to the ECM.
Results

Detachment of non-malignant intestinal epithelial cells triggers upregulation of the IAPs
In an effort to reveal molecular mechanisms that are responsible for the delay of anoikis, we screened spontaneously immortalized non-malignant highly anoikissusceptible intestinal epithelial cells IEC-18 (Rosen et al., 2000) for detachment-induced changes in the expression of various direct regulators of apoptosis. We found that detachment of these cells results in a noticeable upregulation of caspase inhibitors XIAP and cIAP2 both at the protein (Figure 1a and b) and mRNA ( Figure 1c and d) levels. We also observed that a significant upregulation of XIAP ( Figure 1e ) and a relatively weak upregulation of cIAP2 (Figure 1f ) occurs upon detachment of non-malignant anoikis-susceptible cells RIE-1, another cell line that was derived from rat intestinal epithelium (McFall et al., 2001; Rosen et al., 2001) . We further tested whether detachment-induced upregulation of the IAPs takes place in human intestinal epithelial cells DKS-8 that were derived from human colorectal carcinoma cells DLD-1 by targeted disruption of the oncogenic K-ras allele (Shirasawa et al., 1993) . Loss of ras oncogene rendered DKS-8 cells nontumorigenic (Shirasawa et al., 1993) and highly susceptible to death by anoikis (Rosen et al., 2000 (Rosen et al., , 2002 . Similar to what was observed in RIE-1 cells, detachment of DKS-8 cells resulted in a significant upregulation of XIAP (Figure 1g ), but not in that of cIAP2 (not shown). Collectively, our data suggest that IAP-dependent mechanisms triggered by loss of cell-ECM adhesion could delay anoikis of rat and human intestinal epithelial cells.
We reasoned that if this is the case, then detachmentdependent activation of the IAP targets, such as effector caspase-3 and -7 (Deveraux and Reed, 1999) , can be expected to be significantly delayed compared to the timing of the cytosolic translocation of those mitochondrial factors that are known to activate these caspases. Even though the activity of caspase-7 has not yet been tested in attached and detached IEC-18 cells, we found in the past that activation of caspase-3 does occur upon detachment of these cells (Rosen et al., 2001) , suggesting that at least one of the known targets of the IAPs, such as caspase-3, contributes to the execution of anoikis. Effector caspases can be activated by the release of mitochondrial factors, such as cytochrome c, Omi/ HtrA2 and Smac/Diablo into the cytoplasm (Li et al., 1997; Du et al., 2000; Verhagen et al., 2000; Suzuki et al., 2001; Olson and Kornbluth, 2001; Verhagen et al., 2002; Tsujimoto, 2003; Gottfried et al., 2004) . Cytochrome c was proposed to be able to activate initiator caspase-9, which can subsequently trigger effector caspase-3 and -7 (Li et al., 1997) . Omi and Smac in turn are capable of activating these caspases by directly binding to the IAPs and neutralizing them (Du et al., 2000; Verhagen et al., 2002) . The release of mitochondrial factors following detachment of IEC-18 cells can be anticipated to occur in response to detachmentdependent downregulation of the antiapoptotic protein Bcl-X L (Adams and Cory, 1998) , an event that according to our previous studies is at least in part responsible for anoikis of these cells (Rosen et al., 2000) . In agreement with what we observed recently (Liu et al., 2006) , we have found that detachment of IEC-18 cells results in the release of cytochrome c and Omi ( Figure  2a and b), whereas Smac did not translocate to the cytoplasm of these cells upon detachment (Liu et al., 2006) . The release of cytochrome c and Omi occurred as early as 2 h after the loss of cell-ECM adhesion, ( Figure  2a and b) whereas, as might have been expected, detachment-induced activation of both caspase-3 and -7 occurred significantly later than the release of the mitochondrial factors (Figure 2c and d) . Activation of these caspases was not detectable in IEC-18 cells until at least 10 h following detachment (Figure 2c and d) . These data are consistent with our previous observations, according to which a significant degree of anoikis of IEC-18 cells was not observed until 11 h after detachment (Rosen et al., 2000) . Of note, anoikis of primary human intestinal epithelial cells was shown to follow kinetics similar to that observed in our studies (Vachon , 2002) . Thus, our data are consistent with the scenario, according to which detachment-induced upregulation of the IAPs prevents the mitochondrial deathinducing proteins from activating caspases immediately upon release into the cytoplasm and, as a consequence, delays the onset of anoikis. Interestingly, according to our recent studies, it is the release of Omi, rather than the activation of cytochrome c target caspase-9, that appears to mainly contribute to the execution of anoikis of intestinal epithelial cells (Liu et al., 2006) .
Enforced expression of the IAPs in intestinal epithelial cells delays their anoikis
We reasoned that if upregulation of the IAPs delays anoikis, then ectopic expression of these proteins may result in an even more significant attenuation of detachment-induced apoptosis of intestinal epithelial cells. To this end, we measured the ability of exogenous XIAP and cIAP2 to delay anoikis of IEC-18 cells upon transient transfection of these cells with the respective expression vectors. As might have been expected, we found that increased expression of XIAP ( . Therefore, the actual fraction of IEC-18 cells that avoided anoikis in response to enforced expression of the IAPs was likely significantly higher than that shown in Figure 3 . Thus, we conclude that the IAPs are capable of delaying anoikis once their expression is elevated in detached intestinal epithelial cells.
IAP antagonists accelerate anoikis of intestinal epithelial cells
In order to test whether detachment-induced upregulation of the IAPs delays anoikis, we investigated whether inhibition of expression or activity of these antiapoptotic proteins accelerates death of IEC-18 cells upon the loss of adhesion to the ECM. To this end, we first ablated XIAP in IEC-18 cells by a XIAP-specific small interfering RNA (siRNA). We used a non-targeting siRNA as well as an siRNA specific for a regulator of non-apoptotic programmed cell death and autophagy beclin 1 as negative controls. As shown in Figure 4a , transfection with a XIAP siRNA significantly suppressed XIAP expression in IEC-18 cells compared to the control siRNA. This in turn resulted in a noticeable reduction of survival of these cells upon detachment from the ECM (Figure 4b ). Conversely, transfection with a beclin 1 siRNA resulted in a noticeable downregulation of beclin 1, but did not affect the viability of detached cells (not shown).
As, in addition to the upregulation of XIAP, detachment of IEC-18 cells also triggered an increase in cIAP2 expression, we decided to test the effect of enforced downregulation of cIAP2 on anoikis of these cells. In an effort to block the expression of cIAP2 in IEC-18 cells, we tested eight different cIAP2-specific siRNAs and explored various conditions for ablation of cIAP2 by this approach. Surprisingly, we were unable to suppress the expression of cIAP2 by any of the siRNAs selected for the study. The reasons why cIAP2 expression could not be blocked by RNAi are presently unclear and represent the subject of our ongoing research. To demonstrate the causal role of the IAPs in the delay of anoikis by an alternative approach, we reasoned that a direct IAP inhibitor Smac/Diablo has a well-established ability to inactivate both cIAP2 and XIAP (Du et al., 2000) . Thus, Smac can serve as an efficient tool to address the role of these IAPs in anoikis. We, therefore, transiently transfected IEC-18 cells with a plasmid DNA-encoded full-length Smac and measured the levels of detachment-induced apoptosis of these cells compared to those triggered by vector control. As shown in Figure 4c , Smac significantly enhanced anoikis of IEC-18 cells.
To test the role of IAPs in anoikis by a complementary method, we used a cell-permeable Smac-derived peptide. This peptide contained the N-terminal fragment of Smac/Diablo and was shown to be capable of binding IAPs in mammalian cells, suppressing their activity and triggering cell death in a manner similar to that of fulllength Smac (Arnt et al., 2002) . We used the Smac peptide that contains six N-terminal amino acids of Smac fused to the Drosophila Antennapaedia penetratin sequence (cell permeability signal) (Arnt et al., 2002) . We also used mutant Smac peptide in which the first alanine was replaced with methionine as a control. This mutation completely blocks binding of both full-length Smac and cell-permeable Smac peptides to the IAPs (Arnt et al., 2002) . We found that treatment with the Smac peptide resulted in a noticeable decrease of survival of IEC-18 cells upon detachment ( Figure  4d ). Collectively, our data indicate that detachmenttriggered upregulation of the IAPs delays anoikis of intestinal epithelial cells.
Detachment-induced downregulation of Bcl-X L overcomes antiapoptotic effects of the IAPs and thus enhances the effect of other detachment-induced proanoikis signals
We and others have demonstrated that anoikis is executed not by one but several proapoptotic mechanisms. For example, we found that anoikis of IEC-18 cells is simultaneously driven by detachment-induced downregulation of Bcl-X L (Rosen et al., 2000) and upregulation of Fas ligand (Rosen et al., 2002) . In addition, detachment-triggered upregulation of a proapoptotic protein Bim was proposed to contribute to anoikis of these cells (Reginato et al., 2003) .
The reason why the execution of anoikis requires activation of several proapoptotic mechanisms, rather than one, is presently unknown. Based on our findings, we speculated that to trigger anoikis, several detachment-induced proapoptotic signals need to cooperate with each other in overcoming the effect of detachmenttriggered IAP-dependent antiapoptotic signals. To address this hypothesis, we tested whether proapoptotic signals induced by detachment-dependent downregulation of Bcl-X L collaborate with other detachmenttriggered proapoptotic signals in overcoming the antianoikis effect of the IAPs. We reasoned that proanoikis events discussed above cooperate with each other by activating caspases above the level that can be efficiently suppressed by the IAPs. We further speculated that if downregulation of Bcl-X L helps other detachmentinduced signals to induce anoikis by countering the effect of the IAPs, then once downregulation of Bcl-X L is artificially prevented, the remaining death signals (triggered by Fas ligand and possibly Bim) should be able to efficiently execute anoikis only when the activity of the IAPs is blocked. To test this possibility, we used one of several previously published highly anoikisresistant clones of IEC-18 cells in which detachmentinduced downregulation of Bcl-X L was blocked by permanent expression of exogenous Bcl-X L (Rosen et al., 2000) . In agreement with what we published 
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Z Liu et al (Rosen et al., 2000) , stable ectopic expression of Bcl-X L resulted in a strong protection of IEC-18 cells from anoikis ( Figure 5a ). Conversely, exogenously expressed Smac significantly increased the sensitivity of these cells to anoikis despite the presence of ectopic Bcl-X L (Figure 5b ). These data indicate that detachmentinduced proapoptotic signals are capable of efficiently triggering anoikis in the absence of Bcl-X L downregulation only if IAP activity in detached cells is neutralized. To test our hypothesis by an independent method, we measured the ability of the Smac-derived cell-permeable peptide to re-sensitize IEC-BclX cells to anoikis and obtained results similar to those observed with the full-length Smac (Figure 5c and d) . We, therefore, conclude that to be able to trigger anoikis, several detachment-induced proapoptotic signals need to cooperate with each other in overcoming the protective effect of the IAPs.
Detachment-induced upregulation of the IAPs is NF-kB-dependent
As IAP-dependent mechanisms triggered by cell detachment appear to play an important role in the regulation of anoikis, we decided to explore molecular mechanisms that lead to the accumulation of the IAPs in detached cells. We found previously that detachment of IEC-18 cells results in the activation of the transcription factor NF-kB, an antiapoptotic event that noticeably delays anoikis of these cells (Yan et al., 2005) . This role of NF-kB in detachment-induced apoptosis is not unique to IEC-18 cells as, according to a recent study, anoikis of non-malignant rat intestinal epithelial cells RIE-1, is also delayed by detachment-dependent activation of NF-kB (Toruner et al., 2006) . Furthermore, XIAP and cIAP2 are well-established targets of NF-kB that were shown to be upregulated by this transcription factor in various cellular systems (Stehlik et al., 1998; Wang et al., 1998; Biswas et al., 2003) . We, therefore, decided to test whether detachment-induced overexpression of the IAPs is NF-kB-dependent. We first confirmed that, in agreement with our earlier studies (Yan et al., 2005) , the activity of NF-kB reporter gene does increase in IEC-18 upon detachment (Figure 6a ). Furthermore, in support of our previous findings (Yan et al., 2005) , we observed that nuclear fractions isolated from detached IEC-18 cells contained significantly higher levels of NF-kB than those derived from adherent cells (Figure 6b ). It has to be noted here that in the present as well as most of the preceding studies, we deprived IEC-18 cells of adhesion to the ECM by culturing them above a layer of agarose (Rosen et al., 1998 (Rosen et al., , 2000 (Rosen et al., , 2001 (Rosen et al., , 2002 , whereas the recently observed detachment-induced activation of NF-kB was demonstrated for IEC-18 cells placed in a roller culture (Yan et al., 2005) . Collectively, the results of the present study as well as our earlier work (Yan et al., 2005) indicate that detachment-induced activation of NF-kB does not depend on the method used for culturing these cells in suspension.
We further reasoned that if detachment-induced upregulation of the IAPs occurs in an NF-kB-dependent manner, this upregulation should be suppressible by selective pharmacological NF-kB inhibitors, such as caffeic acid phenyl ester (CAPE) (Natarajan et al., 1996) , a compound that has recently been shown to be able to block XIAP expression in breast cancer cells IAPs delay anoikis of intestinal epithelial cells Z Liu et al (Watabe et al., 2004) and enhance apoptosis of detached IEC-18 cells (Rosen et al., 2002) . As expected, we found that treatment of detached IEC-18 cells with CAPE at a concentration that efficiently blocks NF-kB activity in cultured cells without affecting the activity of other transcription factors (Natarajan et al., 1996) caused a noticeable downregulation of both IAPs (Figure 6c and  d) . We, therefore, concluded that detachment-induced upregulation of XIAP and cIAP2 is NF-kB-dependent.
In summary, we identified a novel mechanism responsible for the regulation of the balance between life and death signals in intestinal epithelial signals deprived of the adhesion to the ECM. This mechanism involves detachment-induced activation of IAP-dependent signaling events that lead to the delay of anoikis, and thus determine the timing of this process. We also established that to be able to overcome the antianoikis effect of the IAPs, several proapoptotic signals need to cooperate between each other. Thus, our data explain why the execution of anoikis needs to be driven by several death-inducing mechanisms, rather than one.
Discussion
We have demonstrated in this study that IAPs represent important regulators of the balance between life and death signals that are triggered by the loss of adhesion of non-malignant intestinal epithelial cells to the ECM.
We have established that detachment-induced upregulation of these proteins delays anoikis and thus determines the timing of this process.
We have also found here that detachment-induced increase in the levels of XIAP and cIAP2 is driven by the transcription factor NF-kB. Our results are consistent with various observations, according to which XIAP and cIAP2 represent the targets of this transcription factor in diverse cellular systems (Stehlik et al., 1998; Wang et al., 1998; Biswas et al., 2003) . Furthermore, our data well agree with observations indicating that NF-kB can delay anoikis of intestinal epithelial cells. In this regard, we established previously that detachmentinduced activation of NF-kB delays anoikis of nonmalignant rat intestinal epithelial cells IEC-18 (Yan et al., 2005) . Recently, these results have been supported by findings, according to which detachment-induced activation of this transcription factor delays anoikis of non-malignant cells RIE-1, another cell line derived from rat intestinal epithelium (Toruner et al., 2006) . In agreement with these two studies, we have observed that detachment-induced upregulation of XIAP and cIAP2 occurs both in IEC-18 and RIE-1 cells. The fact that detachment-induced upregulation of cIAP2 was significant in IEC-18 cells, but relatively weak in RIE-1 cells, suggests that NF-kB can support high levels of cIAP2 expression in detached intestinal epithelial cells by cooperating with other yet unidentified cellular signals, the strength of which may depend on the cellular context. It is possible that in case of IEC-18 cells, these signals are activated to a degree that is sufficient for cooperating with NF-kB in inducing a significant upregulation of cIAP2. Conceivably, these signals are weaker in RIE-1 cells and even more so in DKS-8 cells. DKS-8 cells have been derived from colorectal carcinoma cells DLD-1 by ablation of oncogenic ras allele (Shirasawa et al., 1993) and acquired anoikis susceptibility as a result of loss of ras oncogene. These cells, however, still carry other oncogenic mutations (Papadopoulos et al., 1995; Kagawa et al., 1997; Kishida et al., 1998) , some of which could have disrupted the mechanisms that normally control cIAP2 expression. One possible consequence of this is that detachment of DKS-8 cells results in the upregulation of XIAP but not of cIAP2. The fact that, in certain circumstances, NF-kB can regulate the expression of the IAPs in a differential manner has recently been demonstrated by others. It has been shown in this regard that connective tissue growth factor Cyr61 triggers activation of NF-kB and subsequent NF-kB-induced upregulation of XIAP but not of cIAP2 in breast carcinoma cells (Lin et al., 2004) . Of note, detachment-dependent upregulation of XIAP occurred in each cell line tested in this study. Thus, overall, the results presented here support our main conclusion, according to which IAP-dependent mechanisms triggered by loss of cell-ECM adhesion delay anoikis of intestinal epithelial cells.
According to our data, detachment-induced upregulation of the IAPs tightly regulates the timing of anoikis. Presumably, IAPs whose levels increase upon loss of cell-ECM adhesion slow down detachment-dependent accumulation of critical levels of active caspases that are necessary for the execution of programmed cell death. On the other hand, it is conceivable that caspase activity triggered by death-promoting events, such as downregulation of Bcl-X L (Rosen et al., 2000) , upregulation of Fas ligand (Rosen et al., 2002) and possibly Bim (Reginato et al., 2003 ) eventually does reach the threshold level required for the induction of apoptosis. As a consequence, detached cells die by anoikis. Indeed, the opposing effects of detachment-induced anti-and proapoptotic events on cell survival observed in this as well as our previous studies well agree with an established ability of these changes to inhibit or trigger caspases, respectively. Thus, IAPs are thought to exert their antiapoptotic effect by blocking the activity of caspase -9, -3 and -7 (LaCasse et al., 1998; Deveraux and Reed, 1999) . Furthermore, downregulation of Bcl-X L as well as upregulation of the proapoptotic Bcl-2 family members, such as Bim, can be expected to result in the release of death-inducing mitochondrial factors into the cytoplasm. This release can in turn be anticipated to eventually lead to the activation of effector caspase -3 and -7 (Li et al., 1997; Adams and Cory, 1998; van Loo et al., 2002) . As for the overexpression of Fas ligand, this event would be expected to activate Fas receptor and, subsequently, initiator caspase -8 and -10 (Locksley et al., 2001; Ashkenazi, 2002) . Initiator caspase -8 and -10 have an established capacity to trigger caspase-3 and -7 (Li et al., 1997) . Therefore, the ability of the IAPs to inhibit caspases and thus oppose the effect of detachment-induced proapoptotic events on these proteases is likely responsible for the delay of anoikis.
The potential physiological significance of the IAPdependent delay of anoikis stems from the observations, according to which adherent cells partly detach from the ECM during division (Yamakita et al., 1999) . It is possible that the delay in apoptosis induced by the IAPs blocks anoikis of partly detached cells and thus allows them to fully re-establish contacts with the ECM upon completion of cell division without undergoing anoikis. In addition, intestinal epithelial cells were proposed to detach and die by apoptosis in vivo in response to injury . It is tempting to speculate that anoikis of cells that still maintain partial contact with the basement membrane after injury is delayed owing to detachment-induced upregulation of the IAPs. This antiapoptotic mechanism would be expected to allow partly detached cells to re-attach and thus contribute, at least in part, to the restoration of the integrity of intestinal epithelium after injury-caused damage.
Anoikis of various types of non-malignant epithelial cells such as those of intestine, skin and breast is executed by several, rather than one, proapoptotic mechanisms (Rodeck et al., 1997; Rytomaa et al., 1999; Gilmore et al., 2000; Rosen et al., 2000 Rosen et al., , 2002 Puthalakath et al., 2001; Reginato et al., 2003) . The reasons why several death-promoting events are required for the induction of this form of apoptosis have not so far been identified. The results of the present study, at least in part, explain this phenomenon. Our data indicate that to be able to trigger anoikis, proapoptotic signals, such as those triggered by detachment-dependent downregulation of Bcl-X L , need to cooperate with other detachment-induced proapoptotic events (presumably, those dependent on Fas ligand (Rosen et al., 2002) and perhaps Bim (Reginato et al., 2003) ) in overcoming the protective effect of the IAPs. Interestingly, others established that treatment of adherent non-malignant human intestinal epithelial cells (HIECs) with an agonistic anti-Fas antibody results in the overexpression of cIAP2 and cIAP1 (Ruemmele et al., 2002) . Furthermore, treatment of these cells with a proteasome inhibitor or a protein synthesis inhibitor resulted in the downregulation of these IAPs and enhanced the susceptibility of HIEC cells to Fas-induced apoptosis (Ruemmele et al., 2002) . Whether or not signals triggered by Fas ligand whose expression is induced by detachment of intestinal epithelial cells (Rosen et al., 2002) are capable of altering the expression of the IAPs upon loss of cell-ECM adhesion remains to be established. However, importantly, the results of the indicated study (Ruemmele et al., 2002) are consistent with the notion that IAPs are capable of opposing the proapoptotic activity of inducers of anoikis, such as Fas, in intestinal epithelial cells.
If the IAPs represent important regulators of the balance between detachment-induced life and death signals, then increased IAP expression can be expected to occur under pathological conditions when this balance is shifted towards the inhibition of anoikis. Indeed, we have found recently that oncogenic ras triggers upregulation of XIAP and cIAP2 in both rat intestinal epithelial cells IEC-18 and human colorectal carcinoma cells DLD-1 that carry ras oncogene (Liu et al., 2005) . According to our data, detached rastransformed cells display higher levels of these IAPs than their non-malignant counterparts. Furthermore, we have demonstrated that IAP antagonists significantly enhance anoikis of both ras-transformed IEC-18 cells and DLD-1 cells (Liu et al., 2005) , indicating that rasinduced upregulation of the IAPs is required for anoikis resistance of these cells. Not surprisingly, levels of the IAPs, such as XIAP and cIAP2, tend to be elevated in cancers associated with increased frequency of occurrence of oncogenic mutations of ras or with elevated Ras activity. For example, both IAPs were shown to be upregulated in colorectal carcinoma (Krajewska et al., 2005) , a type of cancer that often carries ras oncogene (Bos et al., 1987) . Furthermore, XIAP and cIAP2 are frequently upregulated in lung carcinoma (Ferreira et al., 2001; Hofmann et al., 2002) , another malignancy that often carries oncogenic ras (Rodenhuis et al., 1988) . In addition, expression of both IAPs tends to be elevated in prostate carcinoma (Krajewska et al., 2003) , a disease that is often associated with increased levels of ErbB2 (Signoretti et al., 2000; Shi et al., 2001) , an established inhibitor of anoikis (Reginato et al., 2003) and a known activator of Ras (Satoh et al., 1990) . Finally, according to the recent studies, variants of prostate carcinoma cells selected for increased metastatic capacity displayed elevated levels of XIAP expression and anoikis resistance when compared to their parental poorly metastatic counterparts. Inhibition of XIAP expression in these cells resulted in the suppression of their anoikis resistance and the ability to metastasize (Berezovskaya et al., 2005) .
We conclude that IAPs are important novel regulators of the balance between life and death signals that are triggered by detachment of intestinal epithelial cells from the ECM.
Materials and methods
Cell culture
The generation of the IEC clones expressing BcL-X L was described previously (Rak et al., 1995; Rosen et al., 2000) . IEC-18 and IEC-BclX cells were cultured in a-minimum essential medium (MEM) containing 5% fetal bovine serum (FBS), 10 mg/ml insulin and 0.5% glucose. RIE-1 and DKS-8 cells were cultured in Dulbecco's modified Eagle's medium containing 10% FBS. For suspension, cultures cells were plated above a layer of 1% sea plaque agarose polymerized in a-MEM or Dulbecco's modified Eagle's medium.
Vectors
The generation of expression vectors carrying rat IAP-1 (rat analog of cIAP2) and mouse IAP-3 (mouse analog of XIAP) was described elsewhere (Farahani et al., 1997; Holcik et al., 2002) . Smac expression vector was provided by Dr X Wang (Howard Hughes Medical Institute and Department of Biochemistry, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA). Luciferase reporter vector pNF-kB-Luc vector that carries four copies of the kappa enhancer element (kB 4 ) followed by the herpes simplex virus thymidine kinase promoter and the luciferase gene was from Clontech, Mountain View, CA, USA.
Western blot analysis
Western blot analysis was performed as described elsewhere (Rosen et al., 2000) . The following antibodies were used in this study: anti-RIAP1 (rat analog of cIAP2), anti-RIAP-3 (rat analog of XIAP) (the generation of these two antibodies has been described elsewhere (Holcik et al., 2002) ), anti-cytochrome c (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-Omi/HtrA2 (R&D Systems, Minneapolis, MN, USA), anti-caspase-3 (Santa Cruz Biotechnology), anti-caspase-7 (UBI), anti-RelA (Santa Cruz Biotechnology) and anti-b-actin (Sigma).
Northern blot analysis
Northern blot analysis was performed on total RNA. cDNAs coding for rat IAP-1 (rat analog of cIAP2) (Holcik et al., 2002) and mouse IAP-3 (mouse analog of XIAP) (Farahani et al., 1997) labeled with deoxycytidine triphosphate (dCTP) by random priming were used as probes.
Determination of cytochrome c and Omi/HtrA2 levels in the cytoplasm This procedure has been described elsewhere (Rytomaa et al., 2000) .
NF-kB reporter gene assay A total of 5 Â 10 5 cells were incubated with 2 mg pNFkB-Luc vector in the presence of 2 ml Lipofectamine 2000 (LF2000) (Invitrogen, Carlsbad, CA, USA) in 2 ml Opti-MEM for 4 h at 371C. Medium was changed to regular IEC-18 medium and cells were cultured for another 18-20 h. Cells were further plated in monolayer or suspension and luciferase activity in these cells was then determined using the Enhanced Luciferase Assay kit (BD Pharmingen, San Diego, CA, USA) following the manufacturer's instructions.
Determination of NF-kB levels in nuclear extracts This procedure was previously described by others (Yan et al., 2005) . In brief, cells were washed with ice-cold phosphatebuffered saline (PBS) and then re-suspended in a buffer containing 10 mM Tris, pH 7.8; 10 mM KCl; 1.5 mM ethylenediaminetetraaceticacid (EDTA); 0.5 mM dithiothreitol (DTT); 1 mM phenylmethylsulfonyl fluoride; 0.1 mM Na 3 VO 4 ; 5 mg/ml leupeptin; 5 mg/ml pepstatin; 10 mg/ml aprotinin; 10 mM NaF and 10 mM phenyl arsenoxide. 0.1 volume of 10% NP-40 was then added to cells and cell nuclei were precipitated by centrifugation at 12 000 g for 2 min. Nuclear proteins were then extracted with a buffer containing 20 mM Tris, pH 7.8; 150 mM NaCl; 50 mM KCl; 1.5 mM EDTA and 5 mM DTT in the presence of protease and phosphatase inhibitors for 1 h at 41C. Residual nuclei were removed from the extracts by centrifugation at 12 000 g for 10 min at 41C.
Smac peptide-induced apoptosis assay Cells (10 3 ) were cultured in monolayer or suspension for 72 h in the presence of 80 mg/ml control or Smac peptide. Suspension cells were then re-plated in monolayer and cells were allowed to form colonies for 7 days in the absence of peptides. Colonies were then visualized by crystal Violet Staining and counted. Smac and control peptides were synthesized at the Advanced Protein Technology Centre, The Hospital for Sick Children, Toronto, Ontario, Canada. The sequence of the Smac peptide was AVPIAQRQIKIWFQNRRMKWKK. The sequence of the control peptide was MVPIAQRQIKIWFQNRRMKW KK. The penetratin sequence is underlined.
Full-length Smac-induced apoptosis assay A total of 5 Â 10 5 IEC-18 cells grown in 60 mm dishes were incubated for 4 h with either 2 mg of pcDNA3 or 2 mg of Smac expression vector (provided by Dr X Wang, University of Texas Southwestern Medical Center at Dallas) in the presence of 0.4 mg pEGFP-C1 expression vector (Clontech) and 2 ml of LF2000 (Invitrogen) in OPTI-MEM (Invitrogen) medium. The transfection mixture was subsequently replaced with regular IEC-18 medium and the incubation was continued for another 24 h. Cells were further plated in monolayer and suspension culture for 17 h. Cells were trypsinized, washed with PBS, resuspended in PBS and morphology of GFP-positive cells was then assessed by fluorescent microscopy. Condensed cells were scored as apoptotic.
XIAP RNA interference A total of 5 Â 10 5 IEC-18 cells grown in 60 mm dishes were incubated for 17 h with either 100 nM control non-targeting siRNA or 100 nM XIAP-specific siRNA in the presence of 0.4 mg pEGFP-C1 expression vector (Clontech) and 2 ml of LF2000 (Invitrogen) in OPTI-MEM (GIBCO, Carlsbad, CA, USA) medium. The transfection mixture was subsequently replaced with regular IEC-18 medium and the incubation was continued for another 30 h. Experiments with the nontargeting and beclin 1 siRNAs were performed in a similar manner, except that after transfection cells were incubated for 55, rather than for 30 h. Cells were then cultured in monolayer or suspension for 24 h. Suspension cells were subsequently replated in monolayer and allowed to form colonies for 7 days. Colonies were then visualized by Crystal Violet staining and counted. siRNAs were from Dharmacon, Lafayette, CO, USA. The sequence of the sense strand of the XIAP siRNA was GAAGGGACAAGAAUAUAUAUU. The sequence of the sense strand of the control siRNA (siCONTROL nontargeting siRNA no. 1, Dharmacon) was UAGCGACUAAA CACAUCAAUU. The sequence of the sense strand of the beclin 1 siRNA was GUACCGACUUGUUCCCUAUUU.
IAP-induced survival assay
A total of 5 Â 10 5 IEC-18 cells grown in 60 mm dishes were incubated for 4 h with either 2 mg of pcDNA3 or 2 mg of rat IAP-1 (rat analog of cIAP2) or mouse IAP-3 (mouse analog of XIAP) expression vector in the presence of 2 ml of LF2000 (Invitrogen) in OPTI-MEM (GIBCO) medium. The transfection mixture was subsequently replaced with regular IEC-18 medium and the incubation was continued for another 24 h.
Cells were further plated in monolayer either immediately or after incubation in suspension culture for various periods of time. Cells were allowed to form colonies for 7 days, colonies were then visualized by Crystal Violet staining and counted.
